Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. Current state and prospects of technology development (literature review)

The use of cardiopulmonary bypass (CPB) technologies is often associated with ischemic and re-perfusion injury to the myocardium. The contact of patient’s blood with the surface of the extracorporeal circuit leads to platelets activation and often triggers a systemic inflammatory reaction. Nitric oxide (NO) is a signal molecule produced by the endothelium of blood vessels. Under normal circumstances, it prevents excessive activation and aggregation of platelets, thus providing an organ-protective effect. Currently, there is a considerable amount of data available about positive effects of use of inhaled NO. Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. However, there is a limited amount of publications on effects of NO delivery into gas circuit of oxygenators of artificial and assisted blood circulation. The objective of this article was to summarize currently available information about effects of NO delivery into extracorporeal circuits oxygenators through extensive literature review.

1. Kamenshchikov N. O., Anfinogenova Y. J., Kozlov B. N. et al. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. The Journal of Thoracic and Cardiovascular Surgery, 2022, vol. 163, no. 4, pp. 1393‒1403.e9. https://doi.org/10.1016/j.jtcvs.2020.03.182.

2. Kamenshchikov N. O., Diakova M. L., Podoksenov Y. K. et al. Potential Mechanisms for Organoprotective Effects of Exogenous Nitric Oxide in an Experimental Study. Biomedicines, 2024, vol. 12, no. 4, pp. 719. https://doi.org/10.3390/biomedicines12040719.

3. Kamenshchikov N. O., Mandel I. A., Podoksenov Y. K. et al. Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: randomized trial. The Journal of thoracic and cardiovascular surgery, 2019, vol. 157, no. 6, pp. 2328‒2336.e1. (In Russ.). https://doi.org/10.1016/j.jtcvs.2018.08.117.

4. Marichev A.O., Radovsky A.M., Osovskikh V.V. et al. The effect of nitrogen oxide supplied to the oxygenator on the formation of gas microembolism in the blood circuit of the artificial circulation apparatus (experimental study). Bulletin of Experimental Biology and Medicine, 2024, vol. 177, no. 6, pp. 776‒781. (In Russ.). https://doi.org/10.47056/0365-9615-2024-177-6-776-781.

5. Pichugin V. V., Domnin S. E., Bautin A. E. et al. The influence of various technologies for the use of gaseous nitric oxide on the functional and morphological state of the lungs, markers of myocardial damage and clinical outcomes in cardiosurgical interventions with cardiopulmonary bypass. Pulmonologiya, 2024, vol. 34, no. 3, pp. 364‒374. (In Russ.). https://doi.org/10.18093/0869-0189-2024-34-3-364-374.

6. Radovskiy A. M., Bautin A. E. Marichev A. O. et al. NO Addition during Gas Oxygenation Reduces Liver and Kidney Injury during Prolonged Cardiopulmonary Bypass. Pathophysiology, 2023, vol. 30, no. 4, pp. 484‒504. (In Russ.). https://doi.org/10.3390/pathophysiology30040037.

7. Radovskiy A. M., Vorotyntsev I. V., Atlaskin A. A. et al. The effect of high nitric oxide concentrations on oxygenators in cardiopulmonary bypass machines (Experimental study). General Reanimatology, 2024, vol. 20, no. 1, pp. 50‒62. (In Russ.). https://doi.org/10.15360/1813-9779-2024-1-2351.

8. Annich G. M., Meinhardt J. P., Mowery K. A. et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Critical care medicine, 2000, vol. 28, no. 4, pp. 915‒920. https://doi.org/10.1097/00003246-200004000-00001.

9. Body S. C., FitzGerald D., Voorhees C. et al. Effect of nitric oxide upon gas transfer and structural integrity of a polypropylene membrane oxygenator. ASAIO journal, 1999, vol. 45, no. 6, pp. 550‒554. https://doi.org/10.1097/00002480-199911000-00008.

10. Checchia P. A., Bronicki R. A., Muenzer J. T. et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children – a randomized trial. The Journal of Thoracic and Cardiovascular Surgery, 2013, vol. 146, no. 3, pp. 530‒536. https://doi.org/10.1016/j.jtcvs.2012.09.100.

11. Chiletti R., Horton S., Bednarz A. et al. Safety of nitric oxide added to the ECMO circuit: A pilot study in children. Perfusion, 2018, vol. 33, no. 1, pp. 74‒76. https://doi.org/10.1177/0267659117720495.

12. Comini L., Bachetti T., Agnoletti L. et al. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-α. European heart journal, 1999, vol. 20, no. 20, pp. 1503‒1513. https://doi.org/10.1053/euhj.1999.1580.

13. De Graaf J. C., Banga J. D., Moncada S. et al. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation, 1992, vol. 85, no. 6, pp. 2284‒2290. https://doi.org/10.1161/01.CIR.85.6.2284.

14. Despotis G. J., Avidan M. S., Hogue Jr C. W. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. The Annals of thoracic surgery, 2001, vol. 72, no.5, pp. S1821‒S1831. https://doi.org/10.1016/S0003-4975(01)03211-8.

15. Elzein C., Urbas C., Hughes B. et al. Efficacy of nitric oxide administration in attenuating ischemia/reperfusion injury during neonatal cardiopulmonary bypass. World Journal for Pediatric and Congenital Heart Surgery, 2020, vol. 11, no. 4, pp. 417‒423. https://doi.org/10.1177/2150135120911034.

16. Ignarro L. J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Bioscience reports, 1999, vol. 19, no. 2, pp. 51‒71. https://doi.org/10.1023/a:1020150124721.

17. James C., Millar J., Horton S. et al. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive care medicine, 2016, vol. 42, pp. 1744‒1752. https://doi.org/10.1007/s00134-016-4420-6.

18. Konishi R., Shimizu R., Firestone L. et al. Nitric oxide prevents human platelet adhesion to fiber membranes in whole blood. ASAIO Journal, 1996, vol. 42, no. 5, pp. M850‒853. https://doi.org/10.1097/00002480-199609000-00111.

19. Lei C., Berra L., Rezoagli E. et al. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. American journal of respiratory and critical care medicine, 2018, vol. 198, no. 10, pp. 1279‒1287. https://doi.org/10.1164/rccm.201710-2150OC.

20. Lowson S. M., Hassan H. M., Rich G. F. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit. Anesthesia & Analgesia, 1999, vol. 89, no. 6, pp. 1360. https://doi.org/10.1213/00000539-199912000-00005.

21. Maruyama K., Zhang E., Maruyama J. Clinical application of inhaled nitric oxide. Gas Biology Research in Clinical Practice. Karger Publishers, 2011, pp. 43‒55. https://doi.org/10.1159/000321941.

22. Mellgren K., Friberg L.G., Mellgren G. et al. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. The Annals of thoracic surgery, 1996, vol. 61, no. 4, pp. 1194‒1198. https://doi.org/10.1016/0003-4975(96)00017-3.

23. Niebler R. A., Chiang‐Ching H., Daley K. et al. Nitric oxide added to the sweep gas of the oxygenator during cardiopulmonary bypass in infants: a pilot randomized controlled trial. Artificial Organs, 2021, vol. 45, no. 1, pp. 22‒28. https://doi.org/10.1111/aor.13788.

24. Radomski M. W., Vallance P., Whitley G. et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovascular research, 1993, vol. 27, no. 7, pp. 1380‒1382. https://doi.org/10.1093/cvr/27.7.1380.

25. Rauch E. D., Stammers A. H., Mejak B. L. et al. The effects of nitric oxide on coagulation during simulated extra corporeal membrane oxygenation. The Journal of ExtraCorporeal Technology, 2000, vol. 32, no. 4, pp. 214‒219. https://doi.org/10.1051/ject/2000324214.

26. Rossidis A. C., Lawrence K. M., Mejaddam A. Y. et al. The effects of nitric oxide in oxygenator sweep gas during extracorporeal circulation in a neonatal ovine model. ASAIO Journal, 2020, vol. 66, no. 6, pp. 671‒676. https://doi.org/10.1097/MAT.0000000000001047.

27. Sawicki G., Salas, E., Murat J. et al. Release of gelatinase a during platelet activation mediates aggregation. Nature, 1997, vol. 386, no. 6625, pp. 616‒619. https://doi.org/10.1038/386616a0.

28. Schlapbach L. J., Gibbons K. S., Horton S. B. et al. Effect of nitric oxide via cardiopulmonary bypass on ventilator-free days in young children undergoing congenital heart disease surgery: the NITRIC randomized clinical trial. JAMA, 2022, vol. 328, no. 1, pp. 38‒47. https://doi.org/10.1001/jama.2022.9376.

29. Troncy E., Francœur M., Blaise G. Inhaled nitric oxide: clinical applications, indications, and toxicology. Canadian journal of anaesthesia, 1997, vol. 44, pp. 973‒988. https://doi.org/10.1007/BF03011970.

30. Uchiyama T., Otani H., Okada T. et al. Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. Journal of molecular and cellular cardiology, 2002, vol. 34, no. 8, pp. 1049‒1061. https://doi.org/10.1006/jmcc.2002.2045.

31. Van Dervort A. L., Yan L., Madara P. J. et al. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. Journal of immunology (Baltimore, Md.: 1950), 1994, vol. 152, no. 8, pp. 4102‒4109. https://doi.org/10.4049/jimmunol.152.8.4102.

32. Wan S., LeClerc J. L., Vincent J. L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest, 1997, vol. 112, no. 3, pp. 676‒692. https://doi.org/10.1378/chest.112.3.676.

33. Wu H. W., Li Z. G., Liu G. et al. Effect of nitric oxide inhalation for the treatment of neonatal pulmonary hypertension. Eur Rev Med Pharmacol Sci, 2016, vol. 20, no. 21, pp. 4607‒4611.

34. Xu F., Li W. Delivery exogenous nitric oxide via cardiopulmonary bypass in pediatric cardiac surgery reduces the duration of postoperative mechanical ventilation-A meta-analysis of randomized controlled trials. Heliyon, 2023, vol. 9, no. 8. https://doi.org/10.1016/j.heliyon.2023.e19007.